Foundation Medicine Inc
insurance company / state insurance
Location:
Cambridge, MA,
United States (USA) (US)
Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment (2026)
Khosroyani H, Teuber A, Town A, Klug L, Evans D, Call J, Rothschild S, et al.
Journal article
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study (2023)
Turner NC, Laird AD, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, et al.
Journal article
Advancing digital health applications: priorities for innovation in real-world evidence generation (2022)
Stern AD, Brönneke J, Debatin JF, Hagen J, Matthies H, Patel S, Clay I, et al.
Journal article, Review article